90 related articles for article (PubMed ID: 38750159)
41. m7G Methylation-Related Genes as Biomarkers for Predicting Overall Survival Outcomes for Hepatocellular Carcinoma.
Li XY; Zhao ZJ; Wang JB; Shao YH; Hui-Liu ; You JX; Yang XT
Front Bioeng Biotechnol; 2022; 10():849756. PubMed ID: 35620469
[No Abstract] [Full Text] [Related]
42. Integrating Lipidomics and Transcriptomics Reveals the Crosstalk Between Oxidative Stress and Neuroinflammation in Central Nervous System Demyelination.
Zhao ZJ; Zheng RZ; Wang XJ; Li TQ; Dong XH; Zhao CY; Li XY
Front Aging Neurosci; 2022; 14():870957. PubMed ID: 35547618
[TBL] [Abstract][Full Text] [Related]
43. A Novel Prognostic Model Based on Seven Necroptosis-Related miRNAs for Predicting the Overall Survival of Patients with Lung Adenocarcinoma.
Hong X; Wang G; Pei K; Mo C; Rong Z; Xu G
Biomed Res Int; 2022; 2022():3198590. PubMed ID: 35372581
[TBL] [Abstract][Full Text] [Related]
44. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer.
Chen F; Yang J; Fang M; Wu Y; Su D; Sheng Y
J Clin Lab Anal; 2022 Apr; 36(4):e24302. PubMed ID: 35229919
[TBL] [Abstract][Full Text] [Related]
45. Chinese Admission Warning Strategy for Predicting the Hospital Discharge Outcome in Patients with Traumatic Brain Injury.
Zheng R; Zhuang Z; Zhao C; Zhao Z; Yang X; Zhou Y; Pan S; Chen K; Li K; Huang Q; Wang Y; Ma Y
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207247
[TBL] [Abstract][Full Text] [Related]
46. Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes.
Asare-Werehene M; Tsuyoshi H; Zhang H; Salehi R; Chang CY; Carmona E; Librach CL; Mes-Masson AM; Chang CC; Burger D; Yoshida Y; Tsang BK
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205790
[TBL] [Abstract][Full Text] [Related]
47. Initial CT-based radiomics nomogram for predicting in-hospital mortality in patients with traumatic brain injury: a multicenter development and validation study.
Zheng RZ; Zhao ZJ; Yang XT; Jiang SW; Li YD; Li WJ; Li XH; Zhou Y; Gao CJ; Ma YB; Pan SM; Wang Y
Neurol Sci; 2022 Jul; 43(7):4363-4372. PubMed ID: 35199252
[TBL] [Abstract][Full Text] [Related]
48. Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapy.
Huang X; Qiu M; Wang T; Li B; Zhang S; Zhang T; Liu P; Wang Q; Qian ZR; Zhu C; Wu M; Zhao J
J Nanobiotechnology; 2022 Feb; 20(1):93. PubMed ID: 35193583
[TBL] [Abstract][Full Text] [Related]
49. Two novel prognostic models for ovarian cancer respectively based on ferroptosis and necroptosis.
Li Y; Gong X; Hu T; Chen Y
BMC Cancer; 2022 Jan; 22(1):74. PubMed ID: 35039008
[TBL] [Abstract][Full Text] [Related]
50. Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10.
Li W; Ma JA; Sheng X; Xiao C
World J Surg Oncol; 2021 Nov; 19(1):329. PubMed ID: 34794429
[TBL] [Abstract][Full Text] [Related]
51. Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer.
Zhao Z; Liu H; Zhou X; Fang D; Ou X; Ye J; Peng J; Xu J
J Oncol; 2021; 2021():6718443. PubMed ID: 34790235
[TBL] [Abstract][Full Text] [Related]
52. Untargeted Metabolomic Profiling of Cuprizone-Induced Demyelination in Mouse Corpus Callosum by UPLC-Orbitrap/MS Reveals Potential Metabolic Biomarkers of CNS Demyelination Disorders.
Zhao Z; Li T; Dong X; Wang X; Zhang Z; Zhao C; Kang X; Zheng R; Li X
Oxid Med Cell Longev; 2021; 2021():7093844. PubMed ID: 34567412
[TBL] [Abstract][Full Text] [Related]
53. Identification of CXCL10-Relevant Tumor Microenvironment Characterization and Clinical Outcome in Ovarian Cancer.
Jin J; Li Y; Muluh TA; Zhi L; Zhao Q
Front Genet; 2021; 12():678747. PubMed ID: 34386037
[TBL] [Abstract][Full Text] [Related]
54. Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Wu Y; Zhang X; Wei X; Feng H; Hu B; Deng Z; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Liu J; Wang T
Front Cell Dev Biol; 2021; 9():684643. PubMed ID: 34239875
[TBL] [Abstract][Full Text] [Related]
55. Using Network Distance Analysis to Predict lncRNA-miRNA Interactions.
Zhang L; Yang P; Feng H; Zhao Q; Liu H
Interdiscip Sci; 2021 Sep; 13(3):535-545. PubMed ID: 34232474
[TBL] [Abstract][Full Text] [Related]
56. The Gene Coexpression Analysis Identifies Functional Modules Dynamically Changed After Traumatic Brain Injury.
Zhao ZJ; Wei DP; Zheng RZ; Peng T; Xiao X; Li FS
Comput Math Methods Med; 2021; 2021():5511598. PubMed ID: 33953790
[TBL] [Abstract][Full Text] [Related]
57. Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis.
Han R; Yang H; Lu L; Lin L
Sci Rep; 2021 Apr; 11(1):8626. PubMed ID: 33883691
[TBL] [Abstract][Full Text] [Related]
58. Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma.
Zhou X; Liu C; Zeng H; Wu D; Liu L
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33835133
[TBL] [Abstract][Full Text] [Related]
59. Differences in Tumor Immune Microenvironment in Metastatic Sites of Breast Cancer.
Lee H; Na KJ; Choi H
Front Oncol; 2021; 11():649004. PubMed ID: 33816302
[No Abstract] [Full Text] [Related]
60. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
